These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 8912878

  • 1. Administration of interleukin-10 at the time of priming protects Corynebacterium parvum-primed mice against LPS- and TNF-alpha-induced lethality.
    Smith SR, Terminelli C, Denhardt G, Narula S, Thorbecke GJ.
    Cell Immunol; 1996 Nov 01; 173(2):207-14. PubMed ID: 8912878
    [Abstract] [Full Text] [Related]

  • 2. The cooperative effects of TNF-alpha and IFN-gamma are determining factors in the ability of IL-10 to protect mice from lethal endotoxemia.
    Smith SR, Terminelli C, Kenworthy-Bott L, Calzetta A, Donkin J.
    J Leukoc Biol; 1994 Jun 01; 55(6):711-8. PubMed ID: 8195696
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia.
    Marchant A, Bruyns C, Vandenabeele P, Ducarme M, Gérard C, Delvaux A, De Groote D, Abramowicz D, Velu T, Goldman M.
    Eur J Immunol; 1994 May 01; 24(5):1167-71. PubMed ID: 8181527
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice.
    Tsutsui H, Matsui K, Kawada N, Hyodo Y, Hayashi N, Okamura H, Higashino K, Nakanishi K.
    J Immunol; 1997 Oct 15; 159(8):3961-7. PubMed ID: 9378984
    [Abstract] [Full Text] [Related]

  • 6. Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12.
    Shnyra A, Brewington R, Alipio A, Amura C, Morrison DC.
    J Immunol; 1998 Apr 15; 160(8):3729-36. PubMed ID: 9558074
    [Abstract] [Full Text] [Related]

  • 7. Dibutyryl cyclic AMP protects Corynebacterium parvum-treated mice against lipopolysaccharide-induced lethal toxicity.
    Inoue H, Takahashi S, Nomoto K, Yoshikai Y.
    Cell Immunol; 1995 Apr 15; 162(1):1-7. PubMed ID: 7704897
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice.
    Wysocka M, Kubin M, Vieira LQ, Ozmen L, Garotta G, Scott P, Trinchieri G.
    Eur J Immunol; 1995 Mar 15; 25(3):672-6. PubMed ID: 7705395
    [Abstract] [Full Text] [Related]

  • 9. Alleviation of lipopolysaccharide-induced acute liver injury in Propionibacterium acnes-primed IFN-gamma-deficient mice by a concomitant reduction of TNF-alpha, IL-12, and IL-18 production.
    Tsuji H, Mukaida N, Harada A, Kaneko S, Matsushita E, Nakanuma Y, Tsutsui H, Okamura H, Nakanishi K, Tagawa Y, Iwakura Y, Kobayashi K, Matsushima K.
    J Immunol; 1999 Jan 15; 162(2):1049-55. PubMed ID: 9916732
    [Abstract] [Full Text] [Related]

  • 10. Elevated levels of NO in both unchallenged and LPS-challenged C. parvum-primed mice are attributable to the activity of a cytokine-inducible isoform of iNOS.
    Smith SR, Manfra D, Davies L, Terminelli C, Denhardt G, Donkin J.
    J Leukoc Biol; 1997 Jan 15; 61(1):24-32. PubMed ID: 9000533
    [Abstract] [Full Text] [Related]

  • 11. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha.
    Doherty GM, Lange JR, Langstein HN, Alexander HR, Buresh CM, Norton JA.
    J Immunol; 1992 Sep 01; 149(5):1666-70. PubMed ID: 1506688
    [Abstract] [Full Text] [Related]

  • 12. Lipopolysaccharide-induced cytokine production and mortality in mice treated with Corynebacterium parvum.
    Smith SR, Calzetta A, Bankowski J, Kenworthy-Bott L, Terminelli C.
    J Leukoc Biol; 1993 Jul 01; 54(1):23-9. PubMed ID: 8336076
    [Abstract] [Full Text] [Related]

  • 13. IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production.
    Muchamuel T, Menon S, Pisacane P, Howard MC, Cockayne DA.
    J Immunol; 1997 Mar 15; 158(6):2898-903. PubMed ID: 9058827
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-13 effects on activated monocytes lead to novel cytokine secretion profiles intermediate between those induced by interleukin-10 and by interferon-gamma.
    Minty A, Ferrara P, Caput D.
    Eur Cytokine Netw; 1997 Jun 15; 8(2):189-201. PubMed ID: 9262968
    [Abstract] [Full Text] [Related]

  • 15. Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial origin.
    Satoh M, Inagawa H, Shimada Y, Soma G, Oshima H, Mizuno D.
    J Biol Response Mod; 1987 Oct 15; 6(5):512-24. PubMed ID: 2445926
    [Abstract] [Full Text] [Related]

  • 16. Treatment with Y-40138, a multiple cytokine production modulator, inhibits lipopolysaccharide- or tumour necrosis factor-alpha-induced production of pro-inflammatory cytokines and augments interleukin-10.
    Fukuda T, Hisadome M, Komatsu H.
    J Pharm Pharmacol; 2005 Nov 15; 57(11):1461-6. PubMed ID: 16259779
    [Abstract] [Full Text] [Related]

  • 17. The role of endogenous IFN-gamma, TNF-alpha and IL-10 in LPS-induced nitric oxide release in a mouse model.
    ter Steege JC, van de Ven MW, Forget PP, Brouckaert P, Buurman WA.
    Cytokine; 1998 Feb 15; 10(2):115-23. PubMed ID: 9512901
    [Abstract] [Full Text] [Related]

  • 18. Inflammatory cytokine production in interferon-gamma-primed mice, challenged with lipopolysaccharide. Inhibition by SK&F 86002 and interleukin-1 beta-converting enzyme inhibitor.
    Spinelle-Jaegle S, Devillier P, Doucet S, Millet S, Banissi C, Diu-Hercend A, Ruuth E.
    Eur Cytokine Netw; 2001 Feb 15; 12(2):280-9. PubMed ID: 11399517
    [Abstract] [Full Text] [Related]

  • 19. Endogenous mouse interleukin-10 is up-regulated by exogenously administered recombinant human interleukin-10, but does not contribute to the efficacy of the human protein in mouse models of endotoxemia.
    Smith SR, Terminelli C, Denhardt G, Manfra D, Davies L, Narula S.
    Immunopharmacology; 1999 Feb 15; 41(2):119-30. PubMed ID: 10102793
    [Abstract] [Full Text] [Related]

  • 20. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes.
    Romics L, Dolganiuc A, Velayudham A, Kodys K, Mandrekar P, Golenbock D, Kurt-Jones E, Szabo G.
    J Leukoc Biol; 2005 Dec 15; 78(6):1255-64. PubMed ID: 16204620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.